U.S. Department of Health and Human Services Selects Box for Cloud Content Management

U.S. Department of Health and Human Services Selects Box for Cloud Content Management

REDWOOD CITY, Calif.–(BUSINESS WIRE)–
Box, Inc. (NYSE: BOX), a leading Content Cloud, today announced that the U.S. Department of Health and Human Services, Office of the Secretary (HHS) selected Box’s cloud content management platform to power secure collaboration, critical processes for the delivery of health services, and drive new ways to work in the cloud.

The mission of HHS is to enhance the health and well-being of all Americans, by providing for effective health and human services and by fostering sound, sustained advances in the science underlying medicine, public health, and social services. To help fulfill their mission, HHS is re-thinking how the organization leverages technology, like Box, to modernize their systems for a digital-first agency.

The HHS purchased Box’s Digital Business Suite to:

  • Leverage Box to manage COVID-19 vaccine logistics
  • Secure and classify content using Box Governance and Shield
  • Automate workflows using Box Relay to accelerate delivery on health services
  • Accommodate sharing of large files and real-time access to information for internal and external collaborators

“The HHS is leading the way on how government agencies are leveraging modern technology to better serve the American people and improve mission outcomes,” said Aaron Levie, co-founder and CEO at Box. “The HHS investment in a cloud strategy, including partnerships with companies such as Box, is poised to help the agency provide effective health services to Americans, while ensuring the privacy and security of sensitive data. We are thrilled to support the HHS mission, helping to transform the way they manage and share information.”

Box is FedRAMP compliant and received the Department of Defense SRG Impact Level 4 Authorization by the Defense Information Systems Agency (DISA). With today’s announcement, the HHS joins leading organizations that have moved to Box to power new ways of working, including the U.S. Department of the Air Force, USDA Forest Service and Farm Production and Conservation, Food and Drug Administration, Department of Justice, and the District of Columbia Government.

About Box

Box (NYSE:BOX) is a leading Cloud Content Management platform that enables organizations to accelerate business processes, power workplace collaboration, and protect their most valuable information, all while working with a best-of-breed enterprise IT stack. Founded in 2005, Box simplifies work for leading organizations globally, including AstraZeneca, JLL, and Morgan Stanley. Box is headquartered in Redwood City, CA, with offices in the United States, Europe, and Asia. To learn more about Box, visit http://www.box.com. To learn more about how Box powers nonprofits to fulfill their missions, visit Box.org.

Box PR:

Rachel Levine

[email protected]

Investor Relations:

Elaine Gaudioso

650-209-3467

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Networks Internet Data Management Technology Mobile/Wireless Other Technology Security

MEDIA:

Logo
Logo

Ventev Launches the Industry’s Smallest Four-Lead Dual-Band Antenna

Ventev Launches the Industry’s Smallest Four-Lead Dual-Band Antenna

HUNT VALLEY, Md.–(BUSINESS WIRE)–
Ventev, the manufacturing unit of TESSCO Technologies Incorporated (NASDAQ: TESS), a leading value-added distributor to the wireless infrastructure construction industry, announced the launch of its new Femto Patch Antenna. This is the industry’s smallest, four-lead, dual-band antenna and it is ideal for indoor and outdoor applications where network performance and aesthetics are equally important.

The Femto Patch Antenna is the latest addition to Ventev’s Aesthetic Wi-Fi™ product line. Measuring less than 3 ½ inches square, this antenna is about one-third of the size of comparable directional antennas on the market today.

“At Ventev, our goal is to engineer high performance, aesthetically pleasing product solutions that ensure outstanding coverage and capacity and blend seamlessly into the environment,” said Thad Lowe, General Manager of Ventev. “The new Femto Patch Antenna does exactly that, with the smallest form factor on the market today.”

About Ventev

Ventev, a unit of TESSCO Technologies, Inc., engineers and manufactures industry-leading Wi-Fi and wireless infrastructure products, to ensure reliable network performance and simplify installation of Wi-Fi, IoT, LTE, DAS, and two-way networks. After you choose the radio, choose Ventev to deploy, protect, power, and improve your wireless radio network. For more information, visit ventev.com/infra or connect on Twitter @Ventevinfra.

About TESSCO Technologies Incorporated (NASDAQ: TESS)

TESSCO Technologies, Inc. (NASDAQ: TESS) is a value-added technology distributor, manufacturer, and solutions provider serving commercial customers in the wireless infrastructure ecosystem. The Company was founded more than 30 years ago with a commitment to deliver industry-leading products, knowledge, solutions, and customer service. Tessco supplies more than 65,000 products from 250 of the industry’s top manufacturers in mobile communications, Wi-Fi, Internet of Things (“IoT”), wireless backhaul, and more. Tessco is a single source for outstanding customer experience, expert knowledge, and complete end-to-end solutions for the wireless industry. For more information, visit www.tessco.com.

News Media Contacts:

Cindy King, Tessco

+1 410 229 1161 or [email protected]

KEYWORDS: Maryland United States North America

INDUSTRY KEYWORDS: Technology Manufacturing Other Communications Communications Other Technology Telecommunications Other Manufacturing Networks Internet Mobile/Wireless Hardware

MEDIA:

Logo
Logo

Occupational Health Experts Recommend New Guidelines to Prevent Workplace Illness and Injury

The comprehensive guide is free and includes specific examples of leading health metrics, how to create a balanced set of leading health metrics, and how to implement and measure them in a workplace

Falls Church, Virginia, May 13, 2021 (GLOBE NEWSWIRE) — AIHA, the association for scientists and professionals committed to preserving and ensuring occupational and environmental health and safety (OEHS), announced new guidelines for developing health metrics in workplaces. The leading health metrics guidelines are designed to prevent workplace illness and injury, with an overarching goal for workers to return home as healthy as when they came to work.

“The focus on identifying measures that occur before worker’s health is harmed is critical to safeguarding worker health. AIHA hopes that these guidelines help employers create healthier workplaces and prevent occupational illness and injury in the first place,” said AIHA CEO Lawrence D. Sloan, CAE.

Best Practice Guide for Leading Health Metrics in Occupational Health and Safety Programs is a guide for both practitioners and managers in the broad occupational health community, including industrial hygiene, occupational medicine, occupational health nursing, engineering, and human resources. It applies to businesses of all sizes in all industry sectors, including but not limited to, manufacturing, distribution, healthcare, and nongovernmental organizations.

Leading health metrics – as opposed to lagging health metrics – focus on disease prevention and health promotion. They are measurable, evidence-based indicators that are used to monitor, predict, influence, and manage exposures, hazards and conditions in a workplace that may impact worker health. Health outcomes addressed by leading metrics can be acute, such as eye irritation, dermatitis, or metal fume fever—or they can be chronic, such as elevated blood pressure, hearing loss, or cancer. Leading health metrics can include the number of workers exposed to hazardous noise, number of those who participate in tobacco cessation programs, etc.

Lagging metrics measure after-the-fact occurrences, such as injury and illness rates and prevalence of disease. Unfortunately, lagging metrics are not preventive, as worker health has already been impacted. Because of the lag time between exposure and adverse health effects, such metrics can give false reassurance when the physical manifestation from an adverse exposure is not yet present.

The comprehensive guide is free and includes specific examples of leading health metrics, how to create a balanced set of leading health metrics, and how to implement and measure them in a workplace. Visit http://www.workerhealthsafety.org to download a copy.

About AIHA
AIHA is the association for scientists and professionals committed to preserving and ensuring occupational and environmental health and safety in the workplace and community. Founded in 1939, we support our members with our expertise, networks, comprehensive education programs, and other products and services that help them maintain the highest professional and competency standards. More than half of AIHA’s nearly 8,500 members are Certified Industrial Hygienists and many hold other professional designations. AIHA serves as a resource for those employed across the public and private sectors as well as to the communities in which they work. For more information, please visit www.aiha.org.



Candice Warltier
CS Effect
773-991-1210
[email protected]

PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021

Dr. David Poppers to present on
his initial
experience with Lucid’s EsoCheck and EsoGuard

NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed” or the “Company”), a highly differentiated, multi-product, commercial-stage medical technology company, and its major subsidiary Lucid Diagnostics Inc. (“Lucid”), announced today that David Poppers, M.D. Ph.D. will be presenting data on his team’s initial experience using Lucid’s EsoCheck® Esophageal Cell Collection Device and EsoGuard® Esophageal DNA Test at the upcoming Digestive Disease Week 2021 medical conference, which will be held virtually May 21-23, 2021.

Dr. Poppers is Clinical Professor, Division of Gastroenterology and Hepatology at NYU Langone Medical Center in New York City, and an expert in advanced endoscopy and esophageal disease. His presentation, entitled EsoCheck/EsoGuard: aNovel, Simple, Outpatient Technology for the Early Detection of Esophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma, will be presented during poster session 7110 to be held on Sunday, May 23, 2021 between 12:15 PM and 1 PM EDT.

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. DDW is jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT).

About PAVmed and Lucid

PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company with a diversified product pipeline addressing unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its major subsidiary, Lucid Diagnostics Inc., markets the first and only commercial tools for widespread early detection of esophageal precancer and cancer – the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device. Its GI Health division also includes the complementary EsoCure™ Esophageal Ablation Device with Caldus™ Technology. Its Minimally Invasive Interventions markets its CarpX® Minimally Invasive Device for Carpal Tunnel Syndrome. Other divisions include Infusion Therapy (PortIO™ Implantable Intraosseus Vascular Access Device and NextFlo™ Intravenous Infusion Set), and Emerging Innovations (non-invasive laser-based glucose monitoring, pediatric ear tubes, and mechanical circulatory support). For more information, please visit www.pavmed.com, follow us on Twitter, connect with us on LinkedIn, and watch our videos on YouTube. For more information on our majority owned subsidiary, Lucid Diagnostics Inc., please visit www.luciddx.com, follow Lucid on Twitter, and connect with Lucid on LinkedIn. For detailed information on EsoGuard, please visit www.EsoGuard.com and follow us on Twitter, Facebook and Instagram.

Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, based upon the current beliefs and expectations of PAVmed’s management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Risks and uncertainties that may cause such differences include, among other things, our ability to complete our strategic initiatives, volatility in the price of PAVmed’s common stock, Series W Warrants and Series Z Warrants; general economic and market conditions; the uncertainties inherent in research and development, including the cost and time required advance PAVmed’s products to regulatory submission; whether regulatory authorities will be satisfied with the design of and results from PAVmed’s preclinical studies; whether and when PAVmed’s products are cleared by regulatory authorities; the effectiveness of our marketing initiatives; the establishment of government and private payment insurance coverage; market acceptance of PAVmed’s products once cleared and commercialized; our ability to raise additional funding and other competitive developments. PAVmed has not yet received clearance from the FDA or other regulatory body to market many of its products. The Company has been monitoring the COVID-19 pandemic and its impact on our business. The Company expects the significance of the COVID-19 pandemic, including the extent of its effect on the Company’s financial and operational results, to be dictated by, among other things, the success of efforts to contain it and the impact of actions taken in response. New risks and uncertainties may arise from time to time and are difficult to predict. All of these factors are difficult or impossible to predict accurately and many of them are beyond PAVmed’s control. For a further list and description of these and other important risks and uncertainties that may affect PAVmed’s future operations, see Part I, Item IA, “Risk Factors,” in PAVmed’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as the same may be updated in Part II, Item 1A, “Risk Factors” in any Quarterly Report on Form 10-Q filed by PAVmed after its most recent Annual Report. PAVmed disclaims any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in its expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

Contacts:

Investors

Mike Havrilla
Director of Investor Relations
(814) 241-4138
[email protected]

Media

Shaun O’Neil
Chief Commercial Officer
(518) 812-3087
[email protected]

Jim Heins / Katie Gallagher
LaVoieHealthScience
(646) 491-7042 / (617) 792-3937
[email protected]



Certiverse Wins IT Certification Council’s 2021 Innovation Award

Start-up joins industry icons like IBM and Microsoft as a leader in advancing IT exams

CHICAGO, May 13, 2021 (GLOBE NEWSWIRE) — Certiverse, the first-of-its-kind online exam development system, received the IT Certification Council (ITCC) 2021 Innovation Award, presented May 12 at ITCC’s Spring Member Meeting. This annual award recognizes organizations making transformational changes to an IT exam, company or the industry as a whole.

This is the seventh year the award has been given, with past winners including Microsoft, IBM, SAP, HPE and Certiverse’s inaugural certification client, The Linux Foundation. Launched in 2020, the start-up is the first company at this stage of growth to be honored for its ground-breaking contribution to IT testing.

Certiverse’s online exam development platform applies proprietary, AI-guided tools to help subject matter experts (SMEs) around the world contribute test content asynchronously. Traditionally, this process has involved travel and days-long, in-person workshops, which in the last year have pivoted to extensive virtual meetings. Certiverse’s solution provides greater flexibility and inclusiveness with lower costs, enabling test sponsors to bring relevant exams to market in a fraction of the typical timeframe of 12 to 18 months and pass the cost savings to test-takers.

The effectiveness of this innovation was demonstrated with The Linux Foundation Certified IT Associate exam (LFCA), a new, preprofessional certification testing knowledge of the most current topics in today’s IT workforce. Using Certiverse, The Linux Foundation deployed contributors from 13 countries with no upfront costs and brought the LFCA from concept to launch in 12 weeks. The system’s gamification and revenue-share model encouraged high-quality content to be submitted quickly, and the automated transfer of data streamlined the process from job task analysis to test form creation. Following this implementation, Certiverse signed multiple new clients and closed a $2M series seed financing round.

“We are excited to recognize Certiverse for their incredible work improving exam development tools and processes in a significant and new way,” said Jedi Hammond, ITCC Board of Directors Chairperson. “By building a platform that brings together crowdsourced SMEs, AI and automation, they are able to reduce development time and potential cost for exam development. Now crowdsourcing can be efficiently used for IT certifications as well as IT development!”

“IT certifications have shaped my life and career, and I know how important it is for them to be relevant and within reach to test-takers,” said Certiverse CEO and co-founder Ruben Arturo Garcia. “We built Certiverse so that organizations of any size or testing experience can bring something valid and respected to the certification market, whether that’s a microcredential or a brand-new exam.”

About Certiverse:
Certiverse helps learners succeed by democratizing the exam development process. Its revolutionary online platform uses industry-leading psychometric standards, intuitive machine learning, and asynchronous crowdsourcing from experts to quickly create rigorous, cost-effective exams. Certiverse is an industry innovator, empowering organizations to engage, expand, and diversify their pools of subject matter experts, rapidly develop valid test content at scale, and create exams with less environmental impact.

About ITCC:

The IT Certification Council (ITCC) is a nonprofit organization committed to growing and promoting professional IT certifications. Its core purpose is to support the industry and member companies by marketing the value of certification, promoting exam security, furthering innovation, and establishing and sharing industry best practices. Founded in 2007, ITCC is a community of 40 of the most respected companies in the IT certification industry. Members have access to exclusive resources, collaborate with industry leaders, and engage in task forces working on initiatives to benefit the certification industry. Learn more at www.itcertcouncil.org.



MEDIA CONTACT:
Andria Brown
[email protected]

E-Sports & Video Games For The Win: CEO’s of Activision Blizzard, ESE Entertainment, NetEase, and Enthusiast Gaming – Driving Revenue Growth and Market Share

NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Activision Blizzard, Inc. (NASDAQ: ATVI), ESE Entertainment (TSX.V: ESE) (OTC: ENTEF), Enthusiast Gaming Holdings (NASDAQ: EGLX) and NetEase (NASDAQ: NTES).

ESE Entertainment (TSX.V: ESE) (OTC: ENTEF) CEO Konrad Wasiela: ”E-Sports M&A Pipeline With Over $100 million Annual Revenues”

ESE Entertainment (TSX.V: ESE) (OTC: ENTEF) CEO Konrad Wasiela, a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK investors livestream conference, recently updated investors on his goal of building ESE into a billions dollar global enterprise. Wasiela shared that “ESE now has a growing M&A pipeline with over $100 million annual revenues” and expected to close a significant number of these potential transactions in the coming months. ESE’s stated goal is to build a global E-Sports business with a valuation of $1 Billion+.

May 13 – 1:00PM EST: (OTC: ENTEF) CEO LiveChat:


https://bit.ly/2PX0SpH

Watch ESE (OTC: ENTEF) Next Super Stock livestream video:


https://bit.ly/3qq59mb

In his interview with Wall Street Reporter, ESE CEO Konrad Wasiela, says the company is now ready to scale – expanding its global footprint, with new partnerships with global brands like Porsche, driving revenue growth with aggressive focus on top line sales and margin expansion, and M&A opportunities. ESE is now rapidly expanding, with multiple revenue streams including, E-Sports infrastructure software powering global tournaments, exclusive digital media distribution, broadcast rights, and owning world-class leagues and teams, including its K1CK global E-Sports franchise.

May 13 – ENTEF signs Letter of Intent to acquire Auto Simulation Ltd T/A Digital Motorsports (“Digital Motorsports”), an Irish company that provides infrastructure, technology, and support for esports across the globe – particularly in the simulation racing sector – working with some of the world’s most recognized brands.

April 26 – ENTEF announces Rick Brace is joining its Board of Directors. Mr. Brace most recently served as the President of Rogers Media, the Sports and Media subsidiary of publicly-traded Rogers Communications (RCI). As President of Rogers Media, Rick Brace was responsible for driving strategy and overseeing operations for the company’s robust portfolio of media assets, which includes 42 TV stations, 51 radio stations, 56 publications, digital media, subscription-based content services, the Toronto Blue Jays, and Rogers Centre. Rick Brace commented: “During my time at Rogers it became abundantly clear that traditional media was feeling increasingly stronger headwinds brought on by the rollout and adoption of digital platforms that deliver content in new and innovative ways. Nowhere is this more prevalent than with the growth of esports which is seeing monumental year-over-year growth. ESE (OTC: ENTEF) has positioned itself at the forefront of this movement with a 360 approach, including rights ownership, team ownership, event production and distribution and I am both honoured and excited to join its board and be part of this revolution in our industry”.

April 14 – ENTEF closes acquisition of Esports and gaming infrastructure company, WPG. In 2020, WPG’s assets generated revenue in excess of C$14,000,000. This transaction is anticipated to make ENTEF one of the largest esports infrastructure companies in the world, bridging esports companies with their fans and customers.

May 13 – 1:00PM EST: (OTC: ENTEF) CEO LiveChat:


https://bit.ly/2PX0SpH

Watch ESE (OTC: ENTEF) Next Super Stock livestream video:


https://bit.ly/3qq59mb

Enthusiast Gaming Holdings (NASDAQ: EGLX) (TSE: EGLX) CEO Adrian Montgomery: “The Home for Gen Z and Millennial Video Game and Esports Fans”

“…Enthusiastic Gaming is the home for Gen Z and millennial video game and esports fans. We build communities for these fans that are powered by content, eSports and Entertainment. We connect with over 300 million gamers around the world on a monthly basis across our portfolio of websites, YouTube channels, social media followers of our players and our talent and viewers of our various entertainment offerings….This is the demographic that our business is built on and it underpins our go-to-market strategy with large brands and advertisers trying to connect with this coveted yet increasingly elusive demographic. Every day more and more Gen Z and millennials are leaving traditional social media like Facebook. Where are they going? They’re flocking to our video game communities to maintain social connections with friends, to make new friends. They are also consuming more and more hours of content on YouTube and Twitch. Enthusiasts Gaming’s fan flywheel provides Gen Zs and millennials with the content, the esports and the entertainment that they crave…”

“…Our growth strategy which is built upon a proprietary flywheel that we believe is the right formula to drive meaningful improvements in RPV, or revenue per viewer. Phase 1 was about building scale. Over the last 5 years, our buy and build strategy has focused on building scale both in audience and the experiences we are able to deliver. Combined, we believe we have among the most valuable assets that target Gen Zs and millennials today…Phase 2 focuses on the rapid acceleration of revenue per viewer, achieved through direct sales and optimization within our programmatic ad technology.…”
Enthusiast Gaming Holdings (NASDAQ: EGLX) Earnings Highlights: https://bit.ly/3oal1ZH

Activision Blizzard, Inc. (NASDAQ: ATVI) CEO Bobby Kotick: “Billion Dollar Entertainment Franchises – With Momentum”

“…There are few entertainment franchises that generate over $1 billion in annual net bookings. And today we operate three of them: Call of Duty World of Warcraft and Candy Crush. And each has clear opportunity for sustained growth…For the balance of this year, we’re raising our outlook and we believe we will continue connecting and engaging more players than ever before in 2021.”

“…Call of Duty is the first community to benefit from our pursuit of this franchise based strategy. With over 100 million monthly players, the Call of Duty community is larger than ever before. And with expansion across all platforms the franchise has transformed into a truly social experience that engages and connects our players in truly epic ways. By expanding to mobile, we’ve brought in tens of millions of new players in countries far beyond our traditional audiences. With the game now in final large-scale testing in China and over 50 million players already preregistered, we see a clear path to continue growing Call of Duty’s reach, engagement, and player investment on mobile in the largest mobile gaming market in the world.”

Activision Blizzard, Inc. (NASDAQ: ATVI) Earnings Highlights:


http://bit.ly/34ExR9O

NetEase (NASDAQ: NTES) CEO William Ding: ”Building Global Leader in Digital Entertainment”

“…We grew our net revenues year-over-year by nearly 26% to RMB18.2 billion for this quarter, and our net income from continuing operations attributable to our shareholders grew year-over-year by 35% to RMB4.5 billion. Our online games was up 21% in the second quarter year-over-year, reaching net revenue of RMB13.8 billion, driven by the impressive strength of our existing titles. Our flagship, Fantasy Westward Journey series and Westward Journey series, continued their strong performance in the second quarter. As two of the largest and longest-running game IPs in China, both games consistently attract a loyal crowd…”

“…We are very committed to bringing the richest content to Chinese users by introducing exciting global music and incubating independent musicians. In the second quarter, we launched numerous paid live shows for independent bands, giving them more options to stream online during this uncertain time…Beyond our progress in the domestic market, we have also made multiple headway with our international initiatives. Our overseas online game net revenues hit a new record high in the second quarter, propelled by robust performances from Knives Out and Life-After in Japan……NetEase is best known for our content creation capabilities. This rings true across our different business segments. As we look to the second half of this year, we are more confident and committed than ever to further expanding our reach and bringing relevant, exciting, new products and services to NetEase players, fans and followers around the world…We are excited to lead our next wave of expansion as we continue to build value for all of our stakeholders…”

NetEase (NASDAQ: NTES) Earnings Highlights:


https://bit.ly/3kFMNK9

WALL STREET REPORTER

Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO’s of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter’s NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

CONTACT:

WALL STREET REPORTER

(212) 871-2057 ext 7


www.WallStreetReporter.com



1847 Goedeker and Appliances Connection Announce Record First Quarter 2021 Results with Combined Revenue of $123M, Pro Forma Net Income of $13M and Adjusted EBITDA of $14.7M

1847 Goedeker and Appliances Connection Announce Record First Quarter 2021 Results with Combined Revenue of $123M, Pro Forma Net Income of $13M and Adjusted EBITDA of $14.7M

  • Combined revenue up 84% year-over-year
  • Combined proforma net income $13M in Q1
  • Q1 combined adjusted EBITDA of $14.7M surpassed full-year 2020 adjusted EBITDA of $14.4M

BALLWIN, Mo.–(BUSINESS WIRE)–
1847 Goedeker Inc. (NYSE American: GOED) (“Goedekers” or the “Company”), a one-stop e-commerce destination for appliances and furniture, and Appliances Connection, a leading appliance retailer under a definitive agreement to be acquired by the Company, today reported financial results for the first quarter ended March 31, 2021.

Key Highlights:

  • Appliances Connection acquisition, announced in Q4 2020 and expected to close in Q2 2021.
  • Combined revenue up 84% year-over-year to $123.0 million in the first quarter of 2021, driven by continued strong growth in site sessions, up 61% to 11.1 million, and written orders, up 105% to $199.3 million.
  • Gross profit was $32.2 million for the combined companies, or 26.2% of total first quarter 2021 net revenue, up from 18.9% in the first quarter of 2020.
  • Combined adjusted EBITDA of $14.7 million in the first quarter of 2021 surpassed the proforma adjusted EBITDA of $14.3 million reported by the combined companies for the full year of 2020.
  • As of March 31, 2021, the combined companies had $40.1 million of cash on a proforma basis and $7.1 million in restricted cash.

“On a combined basis we generated exceptional performance in the first quarter with record sales and record EBITDA,” stated Doug Moore, CEO of 1847 Goedeker. “Our first quarter adjusted EBITDA surpassed the entire year’s performance for 2020, with similar strong improvements to our combined net income. We remain on track to complete our acquisition of Appliances Connection in the near term, creating what we believe will be the largest pure-play online retailer of household appliances in the US.”

“A better flow of merchandise in the quarter was combined with a shipped product mix that helped grow product margins to 19.3% at Goedekers and 27% at Appliances Connection,” commented Albert Fouerti, President of Appliances Connection.

Moore continued, “Our order fulfillment abilities are slowly normalizing but still at only 61% versus a historical rate of more than 80%. As manufacturers return to prior production levels and with the opening of our new 86,000 square foot St. Louis fulfillment center, which triples our Midwest capacity, we believe that Goedekers will quickly return to its normal shipping trends.”

Goedekers plans to host a conference call to discuss its first quarter financial results and outlook for 2021 after completing its acquisition of Appliances Connection. The Company will issue a press release with the conference call details after the timing is confirmed.

About 1847 Goedeker Inc.

1847 Goedeker Inc. is an industry leading e-commerce destination for appliances, furniture, and home goods. Since its founding in 1951, Goedekers has transformed from a local brick and mortar operation serving the St. Louis metro area to a respected nationwide omnichannel retailer that offers one-stop shopping for national and global brands. While the Company maintains its St. Louis showroom, over 95% of sales are placed through its website (www.Goedekers.com). Goedeker’s provides visitors an easy to navigate shopping experience and offers more than 141,000 items organized by category and product features. Learn more at www.Goedekers.com.

About Appliances Connection

Founded in 2000, Appliances Connection is one of the leading retailers of household appliances with a 200,000 square foot warehouse in Hamilton, NJ and a 23,000 square foot showroom in Brooklyn, New York. Appliances Connection carries many household name brands, including Bosch, Cafe, Frigidaire Pro, Whirlpool, LG, and Samsung, and also carries many major luxury appliance brands such as Miele, Thermador, La Cornue, Dacor, Ilve, Wolf, Jenn-Air, Viking among others. Appliance Connection provides appliance installation services and appliance removal services. In addition to selling appliances, it also sells furniture, fitness equipment, plumbing fixtures, televisions, outdoor appliances, and patio furniture, as well as commercial appliances for builder and business clients.

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on the Company’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the final prospectus related to the public offering filed with the Securities and Exchange Commission and other reports filed with the Securities and Exchange Commission thereafter. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Non-GAAP Financial Measures

The Company believes the non-GAAP financial measures presented in this press release will help investors understand the financial condition and operating results of the combined company and assess the Company’s future prospects. The Company believes these non-GAAP financial measures, each of which is discussed in greater detail below, are important supplemental measures because they exclude unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of our ongoing operating results. Further, when read in conjunction with GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as a tool to help make financial, operational and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry by providing more comparable measures that are less affected by factors such as capital structure.

The Company recognizes that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. In order to compensate for these and the other limitations discussed below, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with GAAP. Readers should review the reconciliations below and should not rely on any single financial measure to evaluate our business.

The non-GAAP financial measure used in this press release is Adjusted EBITDA. The Company defines Adjusted EBITDA as net loss before income taxes, depreciation and amortization, financing costs, interest expense, sales tax accrual and one-time non-operational events. Adjusted EBITDA is not measures calculated in accordance with GAAP, and they should not be considered an alternative to any financial measures that were calculated under U.S. GAAP. Adjusted EBITDA is used to facilitate a comparison of the ordinary, ongoing and customary course of the operations of the combined company on a consistent basis from period to period and provide an additional understanding of factors and trends affecting the business of the combined company. Adjusted EBITDA may not be comparable to similarly titled non-GAAP measures used by other companies as other companies may have calculated the measures differently.

The reconciliation of Adjusted EBITDA to net loss for the combined company (on a pro forma basis) is provided below:

 

 

 

Three Months Ended

March 31,

2021

 

 

Year Ended

December 31, 2020

 

Net income (loss)

 

$

12,983,184

 

 

$

(6,355,347

)

Income tax expense

 

 

 

 

 

698,303

 

Depreciation and amortization

 

 

275,427

 

 

 

1,332,485

 

Financing costs

 

 

 

 

 

762,911

 

Interest expense

 

 

1,395,836

 

 

 

5,424,521

 

Sales tax accrual

 

 

 

 

 

7,700,378

 

One-time non-operational events:

 

 

 

 

 

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

1,756,095

 

Write-off of acquisition receivable

 

 

 

 

 

809,000

 

Adjustment in value of contingency

 

 

 

 

 

138,922

 

Change on fair value of warrant liability

 

 

 

 

 

2,127,656

 

Adjusted EBITDA

 

$

14,654,447

 

 

$

14,394,924

 

 

Dave Gentry, CEO

RedChip Companies

Office: 1.800.RED.CHIP (733.2447)

Cell: 407.491.4498

[email protected]

KEYWORDS: United States North America Missouri

INDUSTRY KEYWORDS: Retail Online Retail Home Goods Specialty

MEDIA:

Logo
Logo

Global hotel occupancy reaches two-thirds of pre-pandemic levels in April 2021, and hoteliers optimistic for the future according to new Amadeus research

The new report “Rebuilding Hospitality: Trends in Demand, Data and Technology That are Driving Recovery” combines global hotelier insights with Amadeus business intelligence data to surface worldwide hospitality recovery trends.

PR Newswire

PORTSMOUTH, N.H., May 13, 2021 /PRNewswire-PRWeb/ — Since the start of the pandemic, hoteliers have had to rethink many aspects of their business to accommodate new safety procedures, cater to changing guest needs and survive in an extremely complex operating environment. New research from Amadeus reveals how the hospitality industry worldwide has adapted, as well as the trends hoteliers think are likely to stay as the industry rebuilds.

Amadeus’ Demand360® business intelligence data shows that hotel occupancy levels are now on an upward trajectory. Worldwide occupancy reached 46% in April 2021, up from the low point of just 13% in April 2020. This means that global hospitality occupancy has climbed two-thirds of the way back to pre-pandemic norms of around 70% for this time of year.

The data also shows the booking lead time is lengthening, indicating growing consumer confidence to plan ahead. For much of the past year, nearly all reservations across the world were made within 0-7 days of travel. In recent weeks, bookings made on the same day of travel, which are the most problematic for the industry to accommodate, have shrunk globally from 39% the first week of 2021 to 23% the week of April 25, 2021, and 31-60 day bookings increased from 6% the first week of 2021 to 11% the week of April 25, 2021.

The Rebuilding Hospitality report incorporates a survey of 688 global hoteliers delivering new insights into current sentiment and plans:

  • Significant growth optimism: There is a sense of optimism as 30% of hoteliers anticipate opening one or multiple sites in 2021.
  • Leisure travelers are driving recovery: The majority (63%) of hoteliers worldwide think that leisure travel will drive their recovery with domestic leisure by far the highest contributor (45%). In line with this, Amadeus data shows that US, China, and the rest of Asia are starting to see an increase in OTA booking volume, shifting the focus away from a dependence on direct bookings during the pandemic.
  • Recruiting will be a high priority: Over half (59%) of global hoteliers anticipate that they will need to hire new staff in 2021.
  • Opinion on vaccine passports divided amongst hoteliers: Over half of Asian hoteliers say they are considering asking for vaccine passports before permitting guests to stay whereas just under half of hoteliers in the Americas say they will definitely not be adopting this approach. In EMEA, nearly half of hoteliers are uncertain on their strategy in this area.

When considering the aspects of the pandemic pivots that will be here for the longer term, the report reveals:

  • Enhanced hygiene measures are here to stay: A third (32%) of hoteliers think that they will always need significant social distancing, sanitization and visible hygiene measures.
  • Long-term reduction in guest contact and stayover cleans: 20% of global hoteliers indicate they will keep interaction between staff and guests to a minimum for the long term, and 21% plan to reduce daily housekeeping for guests.
  • Personalization could help cross the contactless hospitality divide: Over a quarter of respondents (30%) said that contactless tech to support personalized guest experiences was one of the developments in hospitality they were most excited about as we emerge from the pandemic. Around one in four hoteliers (24%) went on to say they would be turning to technology to support personalized experiences making sure the ‘human touch’ of hospitality is not lost.
  • Work ‘staycations’ and long stay rental investments: Creative business pivots like offering work ‘staycations’ and investment in facilities that help travelers elongate stays have helped hoteliers test out new strategies to access new guest segments. Hoteliers report that these will stay as part of the portfolio for the long-term.

Francisco Pérez-Lozao Rüter, President, Hospitality, Amadeus comments, “The data and trends from this report are intended to draw together insights from hoteliers around the world as we work to-gether as an industry to plan our recovery. With lower restrictions in place, the US market has provided some early indicators of traveler behavior that could help other international hoteliers understand where they are in the stage of their own recovery. One of the key takeaways from our research and report is that technology will play a central role in the recovery of the hospitality industry, as we found globally 41% of hoteliers plan to spend the same or more on IT this year than they did in 2019. At Amadeus, we are committed to investing in our industry and providing the technology that will help ho-tels to pivot their strategies and power future growth.”

Katie Moro, Vice President of Data Partnerships, Hospitality, Amadeus says, “One year on from the start of the pandemic we are really pleased to see the early indications of traveler confidence and an uptick in some hotel bookings. Now, more than ever, data is so critically important across an entire hotel’s business as it informs not only revenue potential but also marketing strategies, staffing and occupancy profile. We want to help hoteliers understand how all the different pieces of data connect together. Data is the foundation that helps you build a better plan and from there, your property is so much stronger from the ground up.”

The Rebuilding Hospitality report highlights the opportunities for hoteliers to rebuild and thrive in 2021 by combining survey data of 688 hoteliers worldwide with the latest insight from Amadeus’ Demand360® business intelligence solution. The survey was managed by Amadeus and conducted anonymously with global hoteliers in March and April 2021. The report seeks to surface hospitality trends that have defined the industry during the pandemic and the best practice examples and advice on how hoteliers can plan for recovery. To learn more about the data and insights, download the report here.

Notes to the editors:

Methodology
Amadeus surveyed 688 hoteliers across the world in March and April 2021 to capture data for this report.

The report incorporates data from Amadeus’ Demand360®, the industry’s only comprehensive forward-looking business intelligence solution. Trusted by more than 30,000 hoteliers worldwide, Demand360® provides 2 years of historical market data plus one year of forward-looking, on-the-books occupancy data to empower hoteliers to create their most profitable revenue strategies and outperform the competition.

About Amadeus
Amadeus powers more personalized and authentic travel experiences. Our solutions are de-signed to enrich every stage of the traveller journey and help hospitality providers acquire, service, and retain guests by profitability driving demand and converting them into loyal fans.

Backed by over 30 years of experience, we design open, cutting-edge software to provide the most efficient, trusted, and reliable systems for our customers. With experts in 175+ coun-tries, we have a deep understanding of the hospitality industry and a desire to enable our hotel partners to create memorable guest experiences.
To find out more about Amadeus, visit http://www.amadeus-hospitality.com.

Media Contact

Sarah Mulder, Fire on the Hill, +44 7720401466, [email protected]

 

SOURCE Amadeus

Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update

Announced positive data from its Phase Ib SPARK study evaluating CM-101 in NAFLD patients

Announced first patient enrolled in two Phase IIa studies of CM-101

Completed merger with Anchiano Therapeutics, and began trading on the Nasdaq Exchange under the ticker CMMB

Cash position of $58.2 million as at March 31, 2021

Strengthened Board of Directors with four new appointments

PR Newswire

TEL-AVIV, Israel, May 13, 2021 /PRNewswire/ — Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced financial and operating results for the first quarter ended March 31, 2021 and provided a business  update.

Chemomab Logo

“This quarter has been truly exciting for Chemomab as we accessed the public markets and began to trade on the Nasdaq exchange, successfully closed on a private offering of $45 million, announced positive data from our Phase Ib study in NAFLD, and initiated a Phase IIa study in PSC.” said Dr. Adi Mor, CEO of Chemomab. “We also started treating patients in our Phase IIa liver fibrosis trial with our subcutaneous formulation of CM-101 and will look to build upon our substantial progress and positive momentum in the coming quarters with the initiation of our additional planned Phase II study of CM-101 in Systemic Sclerosis (SSc). CM-101 is a very promising therapy with the potential to treat multiple severe and life-threatening inflammatory and fibrotic diseases. With a strong financial position, and our unique development track record we believe we are well positioned to continue to advance our pipeline and execute our important milestones this year.”

First Quarter and Recent Highlights

  • Announced positive results from its Phase Ib SPARK study evaluating CM-101 in nonalcoholic fatty liver disease (NAFLD) patients.  The SPARK study was a double-blind, placebo-controlled study designed to evaluate the safety, tolerability and pharmacokinetic (PK) profile of CM-101 in NAFLD patients with normal liver function.  In this study repeated CM-101 administrations were found to be safe and well-tolerated for both tested doses when administered as intravenous (IV) infusion or subcutaneous (SC) injection. No safety signals or unexpected adverse events were observed for CM-101 in either the IV or SC formulation and all reported adverse events were mild or moderate in intensity. Exploratory analysis of multiple pharmacodynamic parameters, including measurement of collagen turnover and fibrotic biomarkers, demonstrated that CM-101 treatment resulted in reduction of fibrotic and fibrogenesis markers compared to no change or slight elevation in the placebo treated group. In addition, there was a reduction in liver stiffness measured by FibroScan in the CM-101 treated group.

 

  • Enrolled the first patient in its Phase IIa SPRING clinical trial of CM-101 for the treatment of patients with primary sclerosing cholangitis (PSC). The SPRING study is a multi-center, randomized, double-blind, placebo-controlled, multiple dose study designed to assess the mechanism of action, safety, pharmacokinetics and pharmacodynamic effects, as well as the antifibrotic effect of IV CM-101 in PSC patients. The trial will enroll and randomize up to 45 patients and is anticipated to complete enrollment by early 2022 with data expected in 1H 2022.

 

  • Enrolled the first patient in its Phase IIa SPLASH clinical trial of CM-101 for the treatment of patients with nonalcoholic
    steato
    hepatitis (NASH). The SPLASH study is a multi-center, randomized, double-blind, placebo-controlled, multiple dose study designed to assess the mechanism of action, safety, pharmacokinetics and pharmacodynamic effects, as well as the anti-fibrotic effects of SC CM-101 in NASH patients with fibrosis stage F2-F3. The trial will enroll 40 patients and is anticipated to complete enrollment by the end of 2021 with data expected in 1H 2022.

 

  • Completed a merger with Anchiano Therapeutics Ltd, and began trading on the Nasdaq Capital Market exchange under the symbol “CMMB” on March 17, 2021.

 

  • Completed the successful pricing of a private placement of $45 million into the combined company led by new and certain existing investors including Cormorant Asset Management, OrbiMed, Peter Thiel, Christian Angermayer’s Presight Capital and Apeiron Investment Group, as well as other healthcare-focused and institutional investors.

 

  • Strengthened its Board of Directors with the appointment of four new directors: Dr. Alan Moses, Dr. Claude Nicaise, Mr. Joel Maryles, and Mr. Neil Cohen. Dr. Stephen Squinto remains as Chairman of Chemomab’s Board, with Dr. Adi Mor and Dr. Nissim Darvish continuing in their roles as Directors.

 

Upcoming Milestones:

Chemomab is advancing in parallel three Phase 2 clinical trials with CM-101 in three distinct fibrotic indications; Systemic Sclerosis (SSc) is planned to be initiated by the end of 2021, and clinical readouts from the ongoing clinical trials in PSC and NASH are expected during 2022. 

First Quarter 2021 Financial Highlights

  • Cashand cash equivalents as of March 31, 2021 were $58.2 million which includes $45.5 million of gross proceeds from the private placement completed on March 22, 2021.

 

  • Research and Development expenses for the three months ended March 31, 2021 were $1.2 million, compared to $1.6 million for the three months ended March 31, 2020. The decrease of $0.4 million was primarily related to a decrease in expenses to sub-contractors.

 

  • General and administrative expenses were $0.5 million for the three months ended March 31, 2021, compared to $0.1 million for the three months ended March 31, 2020.  The increase of $0.4 million was primarily related to merger related expenses.

 

  • Net loss for the three months ended March 31, 2021 and 2020 was $1.7 million.

 

About Chemomab Therapeutics Ltd.

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has potential to treat multiple severe and life-threatening inflammatory and fibrotic diseases and is currently undergoing clinical development with primary focus for the orphan diseases, Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc).

For more information on Chemomab, please visit www.chemomab.com.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits of any product candidates of Chemomab; and that the product candidates have the potential to address high unmet needs of patients with serious fibrosis-related diseases and conditions. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon Chemomab’s current expectations. Forward-looking statements involve risks and uncertainties. Because such statements deal with future events and are based on Chemomab’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Chemomab could differ materially from those described in or implied by the statements in this presentation, including: the uncertain and time-consuming regulatory approval process; risks related to Chemomab’s ability to correctly manage its operating expenses and its expenses; Chemomab’s plans to develop and commercialize its product candidates, focusing on  CM-101; the timing of initiation of Chemomab’s planned clinical trials; the timing of the availability of data from Chemomab’s clinical trials; the timing of any planned investigational new drug application or new drug application; Chemomab’s plans to research, develop and commercialize its current and future product candidates; the clinical utility, potential benefits and market acceptance of Chemomab’s product candidates; Chemomab’s commercialization, marketing and manufacturing capabilities and strategy; Chemomab’s ability to protect its intellectual property position; and the requirement for additional capital to continue to advance these product candidates, which may not be available on favorable terms or at all. Additional risks and uncertainties relating to Chemomab’s and its business can be found under the caption “Risk Factors” and elsewhere in Chemomab’s filings and reports with the SEC. Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Chemomab’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

 

Contact:

Investor Relations:

Irina Koffler

LifeSci Advisors, LLC
Phone: +1-917-734-7387
[email protected]

Chemomab Therapeutics:

Sharon Elkobi
VP, Business Development
Phone: +972773310156
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/chemomab-therapeutics-announces-first-quarter-2021-financial-results-and-provides-a-business-update-301290965.html

SOURCE ChemomAb Ltd.

IIROC Trading Resumption – CUR

Canada NewsWire

VANCOUVER, BC, May 13, 2021 /CNW/ – Trading resumes in:

Company: International Consolidated Uranium Inc.

TSX-Venture Symbol: CUR

All Issues: Yes

Resumption (ET): 9:45 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions